Cellular senescence is a complex stress response defined as an essentially irreversible cell cycle arrest mediated by the inhibition of cell cycle-specific cyclin dependent kinases. The imbalance in redox homeostasis and oxidative stress have been repeatedly observed as one of the hallmarks of the senescent phenotype. However, a large-scale study investigating protein oxidation and redox signaling in senescent cells in vitro has been lacking. Here we applied a proteome-wide analysis using SILAC-iodoTMT workflow to quantitatively estimate the level of protein sulfhydryl oxidation and proteome level changes in ionizing radiation-induced senescence (IRIS) in hTERT-RPE-1 cells. We observed that senescent cells mobilized the antioxidant system to buffer the increased oxidation stress. Among the antioxidant proteins with increased relative abundance in IRIS, a unique 1-Cys peroxiredoxin family member, peroxiredoxin 6 (PRDX6), was identified as an important contributor to protection against oxidative stress. PRDX6 silencing increased ROS production in senescent cells, decreased their resistance to oxidative stress-induced cell death, and impaired their viability. Subsequent SILAC-iodoTMT and secretome analysis after PRDX6 silencing showed the downregulation of PRDX6 in IRIS affected protein secretory pathways, decreased expression of extracellular matrix proteins, and led to unexpected attenuation of senescence-associated secretory phenotype (SASP). The latter was exemplified by decreased secretion of pro-inflammatory cytokine IL-6 which was also confirmed after treatment with an inhibitor of PRDX6 iPLA2 activity, MJ33. In conclusion, by combining different methodological approaches we discovered a novel role of PRDX6 in senescent cell viability and SASP development. Our results suggest PRDX6 could have a potential as a drug target for senolytic or senomodulatory therapy.

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic; BIOCEV 1st Medical Faculty Charles University Vestec Czech Republic

Department of Genome Integrity Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic

Department of Genome Integrity Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic; Danish Cancer Society Research Center Copenhagen Denmark; Department of Medical Biochemistry and Biophysics Division of Genome Biology Science for Life Laboratory Karolinska Institute Stockholm Sweden

See more in PubMed

Di Micco R., Krizhanovsky V., Baker D., d'Adda di Fagagna F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 2021;22:75–95. PubMed PMC

Lee S., Schmitt C.A. The dynamic nature of senescence in cancer. Nat. Cell Biol. 2019;21:94–101. PubMed

Toussaint O., Medrano E.E., von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp. Gerontol. 2000;35:927–945. PubMed

Toussaint O., Weemaels G., Debacq-Chainiaux F., Scharffetter-Kochanek K., Wlaschek M. Artefactual effects of oxygen on cell culture models of cellular senescence and stem cell biology. J. Cell. Physiol. 2011;226:315–321. PubMed

von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002;27:339–344. PubMed

Lee A.C., Fenster B.E., Ito H., Takeda K., Bae N.S., Hirai T., Yu Z.X., Ferrans V.J., Howard B.H., Finkel T. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 1999;274:7936–7940. PubMed

Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88:593–602. PubMed

Kobashigawa S., Kashino G., Mori H., Watanabe M. Relief of delayed oxidative stress by ascorbic acid can suppress radiation-induced cellular senescence in mammalian fibroblast cells. Mech. Ageing Dev. 2015;146–148:65–71. PubMed

Atamna H., Paler-Martinez A., Ames B.N. N-t-butyl hydroxylamine, a hydrolysis product of alpha-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J. Biol. Chem. 2000;275:6741–6748. PubMed

Ameziane-El-Hassani R., Talbot M., de Souza Dos Santos M.C., Al Ghuzlan A., Hartl D., Bidart J.M., De Deken X., Miot F., Diallo I., de Vathaire F., et al. NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation. Proc. Natl. Acad. Sci. U. S. A. 2015;112:5051–5056. PubMed PMC

Hubackova S., Krejcikova K., Bartek J., Hodny Z. IL1- and TGFbeta-Nox 4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine 'bystander senescence. Aging (Albany NY) 2012;4:932–951. PubMed PMC

Weyemi U., Lagente-Chevallier O., Boufraqech M., Prenois F., Courtin F., Caillou B., Talbot M., Dardalhon M., Al Ghuzlan A., Bidart J.M., et al. ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene. 2012;31:1117–1129. PubMed PMC

Weyemi U., Redon C.E., Aziz T., Choudhuri R., Maeda D., Parekh P.R., Bonner M.Y., Arbiser J.L., Bonner W.M. Inactivation of NADPH oxidases NOX4 and NOX5 protects human primary fibroblasts from ionizing radiation-induced DNA damage. Radiat. Res. 2015;183:262–270. PubMed PMC

Correia-Melo C., Passos J.F. Mitochondria: are they causal players in cellular senescence? Biochim. Biophys. Acta Bioenerg. (BBA) 2015;1847:1373–1379. PubMed

Passos J.F., Saretzki G., Ahmed S., Nelson G., Richter T., Peters H., Wappler I., Birket M.J., Harold G., Schaeuble K., et al. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol. 2007;5:e110. PubMed PMC

Vizioli M.G., Liu T., Miller K.N., Robertson N.A., Gilroy K., Lagnado A.B., Perez-Garcia A., Kiourtis C., Dasgupta N., Lei X., et al. Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence. Genes Dev. 2020;34:428–445. PubMed PMC

Rhee S.G., Kang S.W., Chang T.S., Jeong W., Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 2001;52:35–41. PubMed

Soito L., Williamson C., Knutson S.T., Fetrow J.S., Poole L.B., Nelson K.J. PREX: PeroxiRedoxin classification indEX, a database of subfamily assignments across the diverse peroxiredoxin family. Nucleic Acids Res. 2011;39:D332–D337. PubMed PMC

Hampton M.B., O'Connor K.M. Peroxiredoxins and the regulation of cell death. Mol. Cell. 2016;39:72–76. PubMed PMC

Rhee S.G., Kil I.S. Multiple functions and regulation of mammalian peroxiredoxins. Annu. Rev. Biochem. 2017;86:749–775. PubMed

Wood Z.A., Poole L.B., Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science. 2003;300:650–653. PubMed

Chen J.-W., Dodia C., Feinstein S.I., Jain M.K., Fisher A.B. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J. Biol. Chem. 2000;275:28421–28427. PubMed

Fisher A.B. The phospholipase A(2) activity of peroxiredoxin 6. J. Lipid Res. 2018;59:1132–1147. PubMed PMC

Kim T.-S., Sundaresh C.S., Feinstein S.I., Dodia C., Skach W.R., Jain M.K., Nagase T., Seki N., Ishikawa K.-i., Nomura N., et al. Identification of a human cDNA clone for lysosomal type Ca2+-independent phospholipase A2 and properties of the expressed protein. J. Biol. Chem. 1997;272:2542–2550. PubMed

Fisher A.B., Dodia C., Sorokina E.M., Li H., Zhou S., Raabe T., Feinstein S.I. A novel lysophosphatidylcholine acyl transferase activity is expressed by peroxiredoxin 6. JLR (J. Lipid Res.) 2016;57:587–596. PubMed PMC

Arevalo J.A., Vazquez-Medina J.P. The role of peroxiredoxin 6 in cell signaling. Antioxidants. 2018;7 PubMed PMC

Kim S.Y., Jo H.-Y., Kim M.H., Cha Y.-y., Choi S.W., Shim J.-H., Kim T.J., Lee K.-Y. H2O2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activity. J. Biol. Chem. 2008;283:33563–33568. PubMed PMC

Vazquez-Medina J.P., Tao J.Q., Patel P., Bannitz-Fernandes R., Dodia C., Sorokina E.M., Feinstein S.I., Chatterjee S., Fisher A.B. Genetic inactivation of the phospholipase A2 activity of peroxiredoxin 6 in mice protects against LPS-induced acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2019;316:L656–L668. PubMed PMC

Anwar S., Yanai T., Sakai H. Overexpression of peroxiredoxin 6 protects neoplastic cells against apoptosis in canine Haemangiosarcoma. J. Comp. Pathol. 2016;155:29–39. PubMed

He Y., Xu W., Xiao Y., Pan L., Chen G., Tang Y., Zhou J., Wu J., Zhu W., Zhang S., et al. Overexpression of peroxiredoxin 6 (PRDX6) promotes the aggressive phenotypes of esophageal squamous cell carcinoma. J. Cancer. 2018;9:3939–3949. PubMed PMC

Pak J.H., Choi W.H., Lee H.M., Joo W.D., Kim J.H., Kim Y.T., Kim Y.M., Nam J.H. Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells. Cancer Invest. 2011;29:21–28. PubMed

Grueso M.J.L., Valero R.M.T., Carmona H.B., Ruiz D.J.L., Peinado J., McDonagh B., Aguilar R.R., Ruiz J.A.B., Peña C.A.P. Peroxiredoxin 6 down-regulation induces metabolic remodeling and cell cycle arrest in HepG2 cells. Antioxidants. 2019;8:505. PubMed PMC

López-Grueso M.J., Lagal D.J., García-Jiménez Á F., Tarradas R.M., Carmona-Hidalgo B., Peinado J., Requejo-Aguilar R., Bárcena J.A., Padilla C.A. Knockout of PRDX6 induces mitochondrial dysfunction and cell cycle arrest at G2/M in HepG2 hepatocarcinoma cells. Redox biology. 2020;37:101737. PubMed PMC

Knoops B., Argyropoulou V., Becker S., Ferté L., Kuznetsova O. Multiple roles of peroxiredoxins in inflammation. Mol. Cell. 2016;39:60–64. PubMed PMC

Benipal B., Feinstein S.I., Chatterjee S., Dodia C., Fisher A.B. Inhibition of the phospholipase A2 activity of peroxiredoxin 6 prevents lung damage with exposure to hyperoxia. Redox biology. 2015;4:321–327. PubMed PMC

Shanshan Y., Beibei J., Li T., Minna G., Shipeng L., Li P., Yong Z. Phospholipase A2 of peroxiredoxin 6 plays a critical role in cerebral ischemia/reperfusion inflammatory injury. Front. Cell. Neurosci. 2017;11:99. PubMed PMC

Vénéreau E., Ceriotti C., Bianchi M.E. DAMPs from cell death to new life. Front. Immunol. 2015;6 PubMed PMC

Sharapov M.G., Glushkova O.V., Parfenyuk S.B., Gudkov S.V., Lunin S.M., Novoselova E.G. The role of TLR4/NF-kappaB signaling in the radioprotective effects of exogenous Prdx6. Arch. Biochem. Biophys. 2021;702:108830. PubMed

Ho J.N., Lee S.B., Lee S.S., Yoon S.H., Kang G.Y., Hwang S.G., Um H.D. Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells. Mol. Cancer Therapeut. 2010;9:825–832. PubMed

Rolfs F., Huber M., Gruber F., Böhm F., Pfister H.J., Bochkov V.N., Tschachler E., Dummer R., Hohl D., Schäfer M., et al. Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis. Cancer Res. 2013;73:3460–3469. PubMed

Schmitt A., Schmitz W., Hufnagel A., Schartl M., Meierjohann S. Peroxiredoxin 6 triggers melanoma cell growth by increasing arachidonic acid-dependent lipid signalling. Biochem. J. 2015;471:267–279. PubMed

Yun H.-M., Park K.-R., Lee H.P., Lee D.H., Jo M., Shin D.H., Yoon D.-Y., Han S.B., Hong J.T. PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities. Free Radic. Biol. Med. 2014;69:367–376. PubMed

Yun H.M., Park K.R., Park M.H., Kim D.H., Jo M.R., Kim J.Y., Kim E.C., Yoon D.Y., Han S.B., Hong J.T. PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model. Free Radic. Biol. Med. 2015;80:136–144. PubMed

Zha X., Wu G., Zhang H., Yang Y., Zhang Y., Ma L. PRDX6 regulates the H2O2 and blue light-induced APRE-19 cell apoptosis via down-regulating and interacting with RARA. Anim. Cell Syst.(Seoul) 2019;23:241–245. PubMed PMC

Zha X., Wu G., Zhao X., Zhou L., Zhang H., Li J., Ma L., Zhang Y. PRDX6 protects ARPE-19 cells from oxidative damage via PI3K/AKT signaling. Cell. Physiol. Biochem. : Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 2015;36:2217–2228. PubMed

Chhunchha B., Singh P., Stamer W.D., Singh D.P. Prdx6 retards senescence and restores trabecular meshwork cell health by regulating reactive oxygen species. Cell Death Dis. 2017;3:17060. PubMed PMC

Fatma N., Kubo E., Toris C.B., Stamer W.D., Camras C.B., Singh D.P. PRDX6 attenuates oxidative stress- and TGFbeta-induced abnormalities of human trabecular meshwork cells. Free Radic. Res. 2009;43:783–795. PubMed PMC

Vajrychova M., Salovska B., Pimkova K., Fabrik I., Tambor V., Kondelova A., Bartek J., Hodny Z. Quantification of cellular protein and redox imbalance using SILAC-iodoTMT methodology. Redox biology. 2019;24:101227. PubMed PMC

Schagger H. Tricine-SDS-PAGE. Nat. Protoc. 2006;1:16–22. PubMed

Debacq-Chainiaux F., Erusalimsky J.D., Campisi J., Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 2009;4:1798–1806. PubMed

Vancurova M., Hanzlikova H., Knoblochova L., Kosla J., Majera D., Mistrik M., Burdova K., Hodny Z., Bartek J. PML nuclear bodies are recruited to persistent DNA damage lesions in an RNF168-53BP1 dependent manner and contribute to DNA repair. DNA Repair (Amst) 2019;78:114–127. PubMed

Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. PubMed

Victorelli S., Passos J.F. Reactive oxygen species detection in senescent cells. Methods Mol. Biol. 2019;1896:21–29. PubMed

Feoktistova M., Geserick P., Leverkus M. Crystal violet assay for determining viability of cultured cells. Cold Spring Harb. Protoc. 2016 doi: 10.1101/pdb.prot087379. 2016(4):pdb.prot087379. PubMed DOI

Oleksak P., Psotka M., Vancurova M., Sapega O., Bieblova J., Reinis M., Rysanek D., Mikyskova R., Chalupova K., Malinak D., et al. Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition. J. Enzym. Inhib. Med. Chem. 2021;36:410–424. PubMed PMC

Fisher A.B., Dodia C., Chander A., Jain M. A competitive inhibitor of phospholipase A2 decreases surfactant phosphatidylcholine degradation by the rat lung. Biochem. J. 1992;288:407–411. PubMed PMC

Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008;26:1367–1372. PubMed

R Core Team . R Foundation for Statistical Computing; Vienna, Austria: 2020. R: A Language and Environment for Statistical Computing.

Tyanova S., Temu T., Sinitcyn P., Carlson A., Hein M.Y., Geiger T., Mann M., Cox J. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods. 2016;13:731–740. PubMed

Klammer M., Dybowski J.N., Hoffmann D., Schaab C. Identification of significant features by the global mean rank test. PLoS One. 2014;9 PubMed PMC

Cox J., Mann M. 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinf. 2012;13(Suppl 16):S12. PubMed PMC

Huang da W., Sherman B.T., Stephens R., Baseler M.W., Lane H.C., Lempicki R.A. DAVID gene ID conversion tool. Bioinformation. 2008;2:428–430. PubMed PMC

Araki K., Kusano H., Sasaki N., Tanaka R., Hatta T., Fukui K., Natsume T. Redox sensitivities of global cellular cysteine residues under reductive and oxidative stress. J. Proteome Res. 2016;15:2548–2559. PubMed

Leek J.T., Johnson W.E., Parker H.S., Jaffe A.E., Storey J.D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics (Oxford, England) 2012;28:882–883. PubMed PMC

Smyth G.K. In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Gentleman R., Carey V.J., Huber W., Irizarry R.A., Dudoit S., editors. Springer New York; New York, NY: 2005. Limma: linear models for microarray data; pp. 397–420.

Hebert A.S., Richards A.L., Bailey D.J., Ulbrich A., Coughlin E.E., Westphall M.S., Coon J.J. The one hour yeast proteome. Mol. Cell. Proteomics. 2014;13:339–347. PubMed PMC

Bekker-Jensen D.B., Martinez-Val A., Steigerwald S., Ruther P., Fort K.L., Arrey T.N., Harder A., Makarov A., Olsen J.V. A compact quadrupole-orbitrap mass spectrometer with FAIMS interface improves proteome coverage in short LC gradients. Mol. Cell. Proteomics. 2020;19:716–729. PubMed PMC

Willforss J., Chawade A., Levander F. NormalyzerDE: online tool for improved normalization of omics expression data and high-sensitivity differential expression analysis. J. Proteome Res. 2019;18:732–740. PubMed

Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998;273:5858–5868. PubMed

Canovas B., Nebreda A.R. Diversity and versatility of p38 kinase signalling in health and disease. Nat. Rev. Mol. Cell Biol. 2021;22:346–366. PubMed PMC

Ghezzi P., Chan P. Redox proteomics applied to the thiol secretome. Antioxidants Redox Signal. 2017;26:299–312. PubMed

Go Y.-M., Chandler J.D., Jones D.P. The cysteine proteome. Free Radic. Biol. Med. 2015;84:227–245. PubMed PMC

Fisher A.B., Vasquez-Medina J.P., Dodia C., Sorokina E.M., Tao J.-Q., Feinstein S.I. Peroxiredoxin 6 phospholipid hydroperoxidase activity in the repair of peroxidized cell membranes. Redox biology. 2018;14:41–46. PubMed PMC

Basisty N., Kale A., Jeon O.H., Kuehnemann C., Payne T., Rao C., Holtz A., Shah S., Sharma V., Ferrucci L., et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 2020;18 PubMed PMC

Coppé J.P., Patil C.K., Rodier F., Sun Y., Muñoz D.P., Goldstein J., Nelson P.S., Desprez P.Y., Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:2853–2868. PubMed PMC

Michishita E., Nakabayashi K., Suzuki T., Kaul S.C., Ogino H., Fujii M., Mitsui Y., Ayusawa D. 5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species. J. Biochem. 1999;126:1052–1059. PubMed

Davalli P., Mitic T., Caporali A., Lauriola A., D'Arca D. ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases. Oxidative Med. Cell. Longev. 2016:3565127. 2016. PubMed PMC

Sies H., Jones D.P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020;21:363–383. PubMed

Anjo S.I., Melo M.N., Loureiro L.R., Sabala L., Castanheira P., Graos M., Manadas B. oxSWATH: an integrative method for a comprehensive redox-centered analysis combined with a generic differential proteomics screening. Redox biology. 2019:101130. PubMed PMC

Brandes N., Tienson H., Lindemann A., Vitvitsky V., Reichmann D., Banerjee R., Jakob U. Time line of redox events in aging postmitotic cells. eLife. 2013;2 PubMed PMC

Murray C.I., Van Eyk J.E. Chasing cysteine oxidative modifications: proteomic tools for characterizing cysteine redox status. Circ. Cardiovasc. Genet. 2012;5:591. PubMed PMC

Parker J., Balmant K., Zhu F., Zhu N., Chen S. cysTMTRAQ-An integrative method for unbiased thiol-based redox proteomics. Mol. Cell. Proteomics. 2015;14:237–242. PubMed PMC

Shakir S., Vinh J., Chiappetta G. Quantitative analysis of the cysteine redoxome by iodoacetyl tandem mass tags. Anal. Bioanal. Chem. 2017;409:3821–3830. PubMed PMC

Topf U., Suppanz I., Samluk L., Wrobel L., Boser A., Sakowska P., Knapp B., Pietrzyk M.K., Chacinska A., Warscheid B. Quantitative proteomics identifies redox switches for global translation modulation by mitochondrially produced reactive oxygen species. Nat. Commun. 2018;9:324. PubMed PMC

Van Der Reest J., Lilla S., Zheng L., Zanivan S., Gottlieb E. Proteome-wide analysis of cysteine oxidation reveals metabolic sensitivity to redox stress. Nat. Commun. 2018;9 PubMed PMC

Xiao H., Jedrychowski M.P., Schweppe D.K., Huttlin E.L., Yu Q., Heppner D.E., Li J., Long J., Mills E.L., Szpyt J., et al. A quantitative tissue-specific landscape of protein redox regulation during aging. Cell. 2020;180:968–983. e924. PubMed PMC

Yang J., Carroll K.S., Liebler D.C. The expanding landscape of the thiol redox proteome. Mol. Cell. Proteomics. 2016;15:1–11. PubMed PMC

Li Y., Luo Z., Wu X., Zhu J., Yu K., Jin Y., Zhang Z., Zhao S., Zhou L. Proteomic analyses of cysteine redox in high-fat-fed and fasted mouse livers: implications for liver metabolic homeostasis. J. Proteome Res. 2018;17:129–140. PubMed

Menger K.E., James A.M., Cocheme H.M., Harbour M.E., Chouchani E.T., Ding S., Fearnley I.M., Partridge L., Murphy M.P. Fasting, but not aging, dramatically alters the redox status of cysteine residues on proteins in Drosophila melanogaster. Cell Rep. 2015;13:1285. PubMed PMC

Marcotte R., Lacelle C., Wang E. Senescent fibroblasts resist apoptosis by downregulating caspase-3. Mech. Ageing Dev. 2004;125:777–783. PubMed

Sagiv A., Biran A., Yon M., Simon J., Lowe S.W., Krizhanovsky V. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene. 2013;32:1971–1977. PubMed PMC

Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl 2 is involved. Cancer Res. 1995;55:2284–2292. PubMed

Chang J., Wang Y., Shao L., Laberge R.M., Demaria M., Campisi J., Janakiraman K., Sharpless N.E., Ding S., Feng W., et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 2016;22:78–83. PubMed PMC

Yosef R., Pilpel N., Tokarsky-Amiel R., Biran A., Ovadya Y., Cohen S., Vadai E., Dassa L., Shahar E., Condiotti R., et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat. Commun. 2016;7:11190. PubMed PMC

Sanders Y.Y., Liu H., Zhang X., Hecker L., Bernard K., Desai L., Liu G., Thannickal V.J. Histone modifications in senescence-associated resistance to apoptosis by oxidative stress. Redox biology. 2013;1:8–16. PubMed PMC

Youn C.K., Song P.I., Kim M.H., Kim J.S., Hyun J.W., Choi S.J., Yoon S.P., Chung M.H., Chang I.Y., You H.J. Human 8-oxoguanine DNA glycosylase suppresses the oxidative stress induced apoptosis through a p53-mediated signaling pathway in human fibroblasts. Mol. Cancer Res. 2007;5:1083–1098. PubMed

Kim S.Y., Chun E., Lee K.Y. Phospholipase A(2) of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis. Cell Death Differ. 2011;18:1573–1583. PubMed PMC

Eismann T., Huber N., Shin T., Kuboki S., Galloway E., Wyder M., Edwards M.J., Greis K.D., Shertzer H.G., Fisher A.B., et al. Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2009;296:G266–G274. PubMed PMC

Lee D.H., Jung Y.Y., Park M.H., Jo M.R., Han S.B., Yoon D.Y., Roh Y.S., Hong J.T. Peroxiredoxin 6 confers protection against nonalcoholic fatty liver disease through maintaining mitochondrial function. Antioxidants Redox Signal. 2019;31:387–402. PubMed

Ma S., Zhang X., Zheng L., Li Z., Zhao X., Lai W., Shen H., Lv J., Yang G., Wang Q., et al. Peroxiredoxin 6 is a crucial factor in the initial step of mitochondrial clearance and is upstream of the PINK1-parkin pathway. Antioxidants Redox Signal. 2015;24:486–501. PubMed

Birch J., Gil J. Senescence and the SASP: many therapeutic avenues. Genes Dev. 2020;34:1565–1576. PubMed PMC

Faget D.V., Ren Q., Stewart S.A. Unmasking senescence: context-dependent effects of SASP in cancer. Nat. Rev. Cancer. 2019;19:439–453. PubMed

Davalos A.R., Kawahara M., Malhotra G.K., Schaum N., Huang J., Ved U., Beausejour C.M., Coppe J.-P., Rodier F., Campisi J. p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J. Cell Biol. 2013;201:613–629. PubMed PMC

Wiley C.D., Liu S., Limbad C., Zawadzka A.M., Beck J., Demaria M., Artwood R., Alimirah F., Lopez-Dominguez J.A., Kuehnemann C., et al. SILAC analysis reveals increased secretion of hemostasis-related factors by senescent cells. Cell Rep. 2019;28:3329–3337. e3325. PubMed PMC

Blokland K.E.C., Pouwels S.D., Schuliga M., Knight D.A., Burgess J.K. Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases. Clin. Sci. (London, England : 1979) 2020;134:2681–2706. PubMed PMC

Valiente-Alandi I., Potter S.J., Salvador A.M., Schafer A.E., Schips T., Carrillo-Salinas F., Gibson A.M., Nieman M.L., Perkins C., Sargent M.A., et al. Inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure. Circulation. 2018;138:1236–1252. PubMed PMC

Melhem H., Spalinger M.R., Cosin-Roger J., Atrott K., Lang S., Wojtal K.A., Vavricka S.R., Rogler G., Frey-Wagner I. Prdx6 deficiency ameliorates DSS colitis: relevance of compensatory antioxidant mechanisms. J. Crohn's & colitis. 2017;11:871–884. PubMed

Min Y., Wi S.M., Shin D., Chun E., Lee K.-Y. Peroxiredoxin-6 negatively regulates bactericidal activity and NF-κB activity by interrupting TRAF6-ECSIT complex. Front. Cell. Infect. Microbiol. 2017;7 PubMed PMC

Guo J., Cao W., Chen C., Chen X. Peroxiredoxin 6 overexpression regulates adriamycin-induced myocardial injury, oxidative stress and immune response in rats. Ann. Transl. Med. 2020;8:1320. PubMed PMC

Perez-Riverol Y., Csordas A., Bai J., Bernal-Llinares M., Hewapathirana S., Kundu D.J., Inuganti A., Griss J., Mayer G., Eisenacher M., et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442–D450. PubMed PMC

Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics

Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells